Latch Bio
Healthcare Software · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
San Francisco, California, United StatesWebsite
latch.bioRevenue
$15 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
3
2
2
About Latch Bio
LatchBio is a San Francisco-based company on a mission to build and disseminate the data infrastructure for the biocomputing revolution. The companys cloud-based platform offers no-code bioinformatics for scientists seeking to store, transform and visualize their data. Through any web browser, the global scientific community can quickly access popular bioinformatics pipelines and data visualization tools.Explore more
Latch Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Latch Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Latch Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Latch Bio is spiking on competitors!
Latch Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Latch Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Latch Bio recently announced quarterly report
Funding: Get notified immidiatlly once Latch Bio has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Latch Bio had a recent Job posting/layoffs
Product Launch: Get notified when Latch Bio launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Latch Bio
Compare insights from companies similar to Latch Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Latch Bio is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Latch Bio is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Latch Bio.
Latch Bio financials insights
Gather financial insights about Latch Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$5M
2022
Series A
$28M
Latch Bio Tech Stack
A closer look at the technologies used by Latch Bio
See more technologies
Most Recent Scoops
Event
Events
Funding
Funding
Funding
Latch Bio News & Media
Miraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentic AI Framework for Molecular Data Curation
SAN FRANCISCO--(BUSINESS WIRE)--Miraomics, Pythia Biosciences and LatchBio released a 30 million cell atlas spanning over 150 indications, 200 tissue types and 27 measurement technologies curated from public sources. Millions of single cell transcriptomes are scattered across the Internet but remain unused because of the expensive human labor required to structure and annotate this data for downstream use. At this time, these public datasets in aggregate constitute the largest bank of scRNA-seqMiraomics, Pythia Biosciences and LatchBio Release a 30 Million Cell Atlas and an Agentric AI Framework for Molecular Data Curation
SAN FRANCISCO--(BUSINESS WIRE)--Miraomics, Pythia Biosciences and LatchBio released a 30 million cell atlas spanning over 150 indications, 200 tissue types and 27 measurement technologies curated from public sources. Millions of single cell transcriptomes are scattered across the Internet but remain unused because of the expensive human labor required to structure and annotate this data for downstream use. At this time, these public datasets in aggregate constitute the largest bank of scRNA-seqLatchBio Simplifies Access to GPU-Powered Multi-Omics Tools With NVIDIA
SAN FRANCISCO--(BUSINESS WIRE)--LatchBio is building data and pipeline infrastructure to help biotechnology teams access and analyze data at scale. The company is announcing today the release of nineteen accessible AI protein engineering tools, 70% faster multi-omics pipelines, and one-click access to NVIDIA accelerated computing. Protein Engineering tools The 2024 Nobel Prize in Chemistry was awarded for the development of groundbreaking new machine learning methods to understand proteins. ToMeet 'LatchBio', An AI-based Biotech Company That Provides a Code-Free Platform for ...
Meet 'LatchBio', An AI-based Biotech Company That Provides a Code-Free Platform for Bioinformatics Research
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Latch Bio
Sign Up For FreeTo access detailed company insights
LatchBio is a San Francisco-based company on a mission to build and disseminate the data infrastructure for the biocomputing revolution. The companys cloud-based platform offers no-code bioinformatics for scientists seeking to store, transform and visualize their data. Through any web browser, the global scientific community can quickly access popu... Read More
